The rodent model of impaired gastric motility induced by allyl isothiocyanate, a pungent ingredient of wasabi, to evaluate therapeutic agents for functional dyspepsia.


Journal

Journal of pharmacological sciences
ISSN: 1347-8648
Titre abrégé: J Pharmacol Sci
Pays: Japan
ID NLM: 101167001

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 07 05 2020
revised: 03 09 2020
accepted: 26 10 2020
entrez: 28 12 2020
pubmed: 29 12 2020
medline: 14 5 2021
Statut: ppublish

Résumé

Functional dyspepsia (FD) is thought to be mainly based on gastric motility dysfunction and chronic hypersensitivity, yet FD animal models has been reported a few. We studied to establish the mouse model of impaired gastric motility induced by a pungent ingredient of wasabi allyl isothiocyanate (AITC), which is reliable to evaluate prokinetic agents. Male ddY mice were used. Gastric motility was measured by

Identifiants

pubmed: 33357770
pii: S1347-8613(20)30104-3
doi: 10.1016/j.jphs.2020.10.006
pii:
doi:

Substances chimiques

Benzamides 0
Benzyl Compounds 0
Isothiocyanates 0
Morpholines 0
Plant Extracts 0
Thiazoles 0
dai-kenchu-to 0
Neostigmine 3982TWQ96G
itopride 81BMQ80QRL
allyl isothiocyanate BN34FX42G3
Z 338 D42OWK5383
mosapride I8MFJ1C0BY

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122-129

Informations de copyright

Copyright © 2020 The Authors. Production and hosting by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no competing interests.

Auteurs

Kazuki Hashimoto (K)

Laboratory of Pharmacology, Faculty of Pharmaceutical Sciences, Josai International University, 1 Gumyo, Togane, Chiba, 283-8555, Japan.

Kimihito Tashima (K)

Laboratory of Pharmacology, Faculty of Pharmaceutical Sciences, Josai International University, 1 Gumyo, Togane, Chiba, 283-8555, Japan; Center of Pharmacological Kampo Research, Josai International University, 1 Gumyo, Togane, Chiba, 283-8555, Japan. Electronic address: ktashima@jiu.ac.jp.

Taku Imai (T)

Laboratory of Pharmacology, Faculty of Pharmaceutical Sciences, Josai International University, 1 Gumyo, Togane, Chiba, 283-8555, Japan.

Kenjiro Matsumoto (K)

Division of Pathological Sciences, Department of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical University, Yamashina, Kyoto, 607-8414, Japan.

Syunji Horie (S)

Laboratory of Pharmacology, Faculty of Pharmaceutical Sciences, Josai International University, 1 Gumyo, Togane, Chiba, 283-8555, Japan; Center of Pharmacological Kampo Research, Josai International University, 1 Gumyo, Togane, Chiba, 283-8555, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH